National Institute of Allergy and Infectious Diseases Director Dr. Anthony Fauci says a study out of China disputing the treatment efficacy of the drug Remdisivir in treating COVID-19 symptoms is “underpowered.”
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.